C
4.80
-0.30 (-5.89%)
| Previous Close | 5.10 |
| Open | 4.70 |
| Volume | 231,148 |
| Avg. Volume (3M) | 1,227,268 |
| Market Cap | 226,494,224 |
| Price / Sales | 436.42 |
| Price / Book | 3.76 |
| 52 Weeks Range |
| Diluted EPS (TTM) | -1.74 |
| Total Debt/Equity (MRQ) | 20.31% |
| Current Ratio (MRQ) | 2.77 |
| Operating Cash Flow (TTM) | -27.02 M |
| Levered Free Cash Flow (TTM) | 7.38 M |
| Return on Assets (TTM) | -27.55% |
| Return on Equity (TTM) | -139.56% |
Market Trend
| Short Term | Medium Term | ||
| Industry | Biotechnology (US) | Bearish | Bearish |
| Biotechnology (Global) | Bearish | Bearish | |
| Stock | Candel Therapeutics, Inc. | Bearish | Bullish |
AIStockmoo Score
0.5
| Analyst Consensus | 3.0 |
| Insider Activity | NA |
| Price Volatility | 0.5 |
| Technical Moving Averages | 2.5 |
| Technical Oscillators | -4.0 |
| Average | 0.50 |
|
Candel Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing and commercializing viral immunotherapies to help patients fight cancer. The company has established two clinical-stage viral immunotherapy platforms based on novel, genetically modified adenovirus and herpes simplex virus (HSV) constructs, respectively. |
|
| Sector | Healthcare |
| Industry | Biotechnology |
| Investment Style | Small Core |
| % Held by Insiders | 17.77% |
| % Held by Institutions | 43.55% |
Ownership
| Name | Date | Shares Held |
|---|---|---|
| Northpond Ventures, Llc | 30 Sep 2024 | 1,935,215 |
| Sands Capital Ventures, Llc | 31 Dec 2024 | 405,837 |
| 52 Weeks Range | ||
| Price Target Range | ||
| High | 25.00 (Citigroup, 421.38%) | Buy |
| 25.00 (Canaccord Genuity, 421.38%) | Buy | |
| Median | 25.00 (421.38%) | |
| Low | 19.00 (HC Wainwright & Co., 296.25%) | Buy |
| Average | 23.00 (379.67%) | |
| Total | 3 Buy | |
| Avg. Price @ Call | 8.55 | |
| Firm | Date | Target Price | Call | Price @ Call |
|---|---|---|---|---|
| HC Wainwright & Co. | 11 Apr 2025 | 19.00 (296.25%) | Buy | 4.97 |
| 14 Mar 2025 | 19.00 (296.25%) | Buy | 8.75 | |
| Canaccord Genuity | 26 Feb 2025 | 25.00 (421.38%) | Buy | 8.47 |
| 19 Feb 2025 | 20.00 (317.10%) | Buy | 10.47 | |
| Citigroup | 20 Feb 2025 | 25.00 (421.38%) | Buy | 12.21 |
No data within this time range.
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2025 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |